Raymond James analyst C. Gregory Peters notes that Health Insurance Innovations' shares are under pressure on news of a new investigation by House Democrats into the short-term/limited-duration health insurance market, which should "not come as a surprise." The analyst notes that the products sold by the company are regulated at the state level and it just recently resolved a major multistate market conduct examination that did not identify any issues. Overall, Peters views the selloff in the stock as an "irrational overreaction" with zero fundamental basis. He reiterates an Outperform rating on the shares.